Corporate news

Find here Marinomed’s corporate news and Ad-hoc news.

21.07.2022
Marinomed to pause issuing of tranches of Convertible Notes Funding Program to Nice & Green

Press release

15.06.2022
Marinomed Biotech AG: Annual General Meeting elects Dr. Elisabeth Lackner and Ulrich Kinzel to the Supervisory Board

Press release

23.05.2022
Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose

Press release

19.05.2022
Marinomed Biotech AG enters into license agreement with Procter & Gamble on Carragelose® products

Adhoc-Announcement

Lucia Mayr-Harting, MSc
Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com